Topoisomerase IB: a relaxing enzyme for stressed DNA
- PMID: 35582040
- PMCID: PMC9094055
- DOI: 10.20517/cdr.2019.106
Topoisomerase IB: a relaxing enzyme for stressed DNA
Abstract
DNA topoisomerase I enzymes relieve the torsional strain in DNA; they are essential for fundamental molecular processes such as DNA replication, transcription, recombination, and chromosome condensation; and act by cleaving and then religating DNA strands. Over the past few decades, scientists have focused on the DNA topoisomerases biological functions and established a unique role of Type I DNA topoisomerases in regulating gene expression and DNA chromosome condensation. Moreover, the human enzyme is being investigated as a target for cancer chemotherapy. The active site tyrosine is responsible for initiating two transesterification reactions to cleave and then religate the DNA backbone, allowing the release of superhelical tension. The different steps of the catalytic mechanism are affected by various inhibitors; some of them prevent the interaction between the enzyme and the DNA while others act as poisons, leading to TopI-DNA lesions, breakage of DNA, and eventually cellular death. In this review, our goal is to provide an overview of mechanism of human topoisomerase IB action together with the different types of inhibitors and their effect on the enzyme functionality.
Keywords: Human DNA topoisomerase IB; drugs inhibition; mechanism of action.
© The Author(s) 2020.
Conflict of interest statement
All authors declared that there are no conflicts of interest.
Figures




Similar articles
-
[Poisons of DNA topoisomerases I and II].Bull Cancer. 1993 Nov;80(11):923-54. Bull Cancer. 1993. PMID: 8081034 Review. French.
-
Topoisomerase 1B poisons: Over a half-century of drug leads, clinical candidates, and serendipitous discoveries.Med Res Rev. 2019 Jul;39(4):1294-1337. doi: 10.1002/med.21546. Epub 2018 Nov 19. Med Res Rev. 2019. PMID: 30456874 Review.
-
Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB.Nature. 2005 Mar 31;434(7033):671-4. doi: 10.1038/nature03395. Nature. 2005. PMID: 15800630
-
Structural insights into the function of type IB topoisomerases.Curr Opin Struct Biol. 1999 Feb;9(1):29-36. doi: 10.1016/s0959-440x(99)80005-0. Curr Opin Struct Biol. 1999. PMID: 10047584
-
Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.Infect Disord Drug Targets. 2007 Mar;7(1):3-9. doi: 10.2174/187152607780090748. Infect Disord Drug Targets. 2007. PMID: 17346206 Review.
Cited by
-
Differential cellular localization of DNA gyrase and topoisomerase IB in response to DNA damage in Deinococcus radiodurans.Extremophiles. 2023 Dec 7;28(1):7. doi: 10.1007/s00792-023-01323-1. Extremophiles. 2023. PMID: 38062175
-
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer.Anticancer Agents Med Chem. 2024;24(4):236-262. doi: 10.2174/0118715206269722231121173311. Anticancer Agents Med Chem. 2024. PMID: 38038012 Review.
-
Elucidating the molecular mechanisms underlying the induction of autophagy by antidepressant-like substances in C57BL/6J mouse testis model upon LPS challenge.Cell Commun Signal. 2023 Sep 21;21(1):251. doi: 10.1186/s12964-023-01270-6. Cell Commun Signal. 2023. PMID: 37735683 Free PMC article.
-
Innovation through Tradition: The Current Challenges in Cancer Treatment.Int J Mol Sci. 2022 May 10;23(10):5296. doi: 10.3390/ijms23105296. Int J Mol Sci. 2022. PMID: 35628105 Free PMC article.
-
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity.Int J Mol Sci. 2025 Jan 24;26(3):988. doi: 10.3390/ijms26030988. Int J Mol Sci. 2025. PMID: 39940757 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous